Interview: Lead Researcher for CheckMate-577 Clinical Trial
Ronan Kelly, MD, MBA, the system’s Dallas-Fort Worth chief of oncology and director of oncology at Baylor Scott & White Charles A. Sammons Cancer Center and the W.W. Caruth Jr. Chair of Immunology at Baylor University Medical Center in Dallas, was the lead author of the recently released NEJM article.